Education
About Us
Working with TipRanks
Follow Us
NextCell Pharma AB (SE:NXTCL)
FRANKFURT:NXTCL
| Dec 25 | Dec 25 | Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 10.94M | - | kr 10.66M | kr 10.11M | kr 5.59M |
| Gross Profit | kr -35.87M | - | kr -4.56M | kr -884.83K | kr -22.26M |
| Operating Income | kr -35.87M | - | kr -43.17M | kr -41.00M | kr -35.02M |
| EBITDA | kr -32.63M | - | kr -40.99M | kr -39.36M | kr -34.10M |
| Net Income | kr -35.14M | - | kr -41.96M | kr -39.81M | kr -34.08M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 38.72M | kr ― | kr 46.79M | kr 50.03M | kr 97.12M |
| Total Assets | kr 76.73M | - | kr 81.29M | kr 88.83M | kr 124.66M |
| Total Debt | kr 0.00 | - | kr 0.00 | kr 0.00 | kr 0.00 |
| Net Debt | kr -38.72M | - | kr -46.79M | kr -50.03M | kr -97.12M |
| Total Liabilities | kr 10.34M | - | kr 13.69M | kr 13.10M | kr 9.12M |
| Stockholders' Equity | kr 66.39M | kr ― | kr 67.60M | kr 75.73M | kr 115.54M |
| Cash Flow | |||||
| Free Cash Flow | kr -43.05M | - | kr -37.86M | kr -47.92M | kr -40.90M |
| Operating Cash Flow | kr -38.86M | - | kr -37.78M | kr -43.83M | kr -33.31M |
| Investing Cash Flow | kr -4.24M | - | kr -83.51K | kr -4.10M | kr -9.37M |
| Financing Cash Flow | kr 35.03M | - | kr 34.63M | kr 835.66K | kr 608.17K |